Met Life Investment Management, LLC Enanta Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 11,454 shares of ENTA stock, worth $60,133. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,454
Previous 11,454 -0.0%
Holding current value
$60,133
Previous $148,000 20.27%
% of portfolio
0.0%
Previous 0.0%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$11.43 - $17.02 $12,733 - $18,960
1,114 Added 10.77%
11,454 $148,000
Q1 2024

May 14, 2024
BUY
$10.08 - $17.46 $104,227 - $180,536
10,340 New
10,340 $180,000
Q2 2023

Apr 29, 2024
BUY
$20.68 - $39.85 $213,831 - $412,049
10,340 New
10,340 $221,000
Q1 2023

May 09, 2024
BUY
$38.82 - $54.59 $401,398 - $564,460
10,340 New
10,340 $418 Million
Q3 2022

May 10, 2024
SELL
$48.29 - $71.27 $29,891 - $44,116
-619 Reduced 5.65%
10,340 $536,000
Q3 2022

Mar 22, 2023
SELL
$48.29 - $71.27 $29,891 - $44,116
-619 Reduced 5.65%
10,340 $536,000
Q3 2022

Nov 14, 2022
SELL
$48.29 - $71.27 $29,891 - $44,116
-619 Reduced 5.65%
10,340 $536,000
Q2 2022

Jun 20, 2023
BUY
$38.13 - $76.93 $23,602 - $47,619
619 Added 5.99%
10,959 $518,000
Q1 2022

May 10, 2024
BUY
$56.06 - $74.11 $614,361 - $812,171
10,959 New
10,959 $780,000
Q1 2022

Jun 20, 2023
BUY
$56.06 - $74.11 $34,701 - $45,874
619 Added 5.99%
10,959 $780,000
Q1 2022

Mar 22, 2023
BUY
$56.06 - $74.11 $232,032 - $306,741
4,139 Added 60.69%
10,959 $780,000
Q1 2022

May 12, 2022
BUY
$56.06 - $74.11 $232,032 - $306,741
4,139 Added 60.69%
10,959 $780,000
Q4 2021

Jun 21, 2023
SELL
$60.19 - $97.37 $211,868 - $342,742
-3,520 Reduced 34.04%
6,820 $509,000
Q3 2021

May 17, 2024
SELL
$41.02 - $58.65 $60,463 - $86,450
-1,474 Reduced 17.77%
6,820 $387,000
Q3 2021

Jun 21, 2023
SELL
$41.02 - $58.65 $144,390 - $206,448
-3,520 Reduced 34.04%
6,820 $387,000
Q3 2021

Mar 22, 2023
SELL
$41.02 - $58.65 $60,463 - $86,450
-1,474 Reduced 17.77%
6,820 $387,000
Q3 2021

Nov 15, 2021
SELL
$41.02 - $58.65 $60,463 - $86,450
-1,474 Reduced 17.77%
6,820 $387,000
Q2 2021

Jun 21, 2023
SELL
$43.76 - $53.11 $89,532 - $108,663
-2,046 Reduced 19.79%
8,294 $365,000
Q1 2021

May 17, 2024
SELL
$41.69 - $54.95 $85,297 - $112,427
-2,046 Reduced 19.79%
8,294 $409,000
Q1 2021

Jun 26, 2023
SELL
$41.69 - $54.95 $85,297 - $112,427
-2,046 Reduced 19.79%
8,294 $409 Million
Q4 2020

Jun 22, 2023
SELL
$41.16 - $47.47 $84,213 - $97,123
-2,046 Reduced 19.79%
8,294 $349,000
Q3 2020

Jun 26, 2023
SELL
$43.36 - $53.53 $88,714 - $109,522
-2,046 Reduced 19.79%
8,294 $379,000
Q2 2020

May 24, 2024
SELL
$46.37 - $57.58 $94,873 - $117,808
-2,046 Reduced 19.79%
8,294 $416 Million
Q2 2020

Jun 26, 2023
SELL
$46.37 - $57.58 $94,873 - $117,808
-2,046 Reduced 19.79%
8,294 $416,000
Q1 2020

Jul 12, 2023
SELL
$40.22 - $62.0 $82,290 - $126,852
-2,046 Reduced 19.79%
8,294 $426,000
Q1 2020

Mar 22, 2023
BUY
$40.22 - $62.0 $27,993 - $43,152
696 Added 9.16%
8,294 $426,000
Q1 2020

May 15, 2020
BUY
$40.22 - $62.0 $27,993 - $43,152
696 Added 9.16%
8,294 $427,000
Q4 2019

Jul 12, 2023
SELL
$57.95 - $66.61 $158,898 - $182,644
-2,742 Reduced 26.52%
7,598 $469,000
Q3 2019

Jul 12, 2023
SELL
$60.08 - $88.17 $164,739 - $241,762
-2,742 Reduced 26.52%
7,598 $456,000
Q2 2019

Jul 12, 2023
SELL
$81.3 - $97.35 $222,924 - $266,933
-2,742 Reduced 26.52%
7,598 $641,000
Q1 2019

Jul 13, 2023
SELL
$69.08 - $105.66 $189,417 - $289,719
-2,742 Reduced 26.52%
7,598 $725,000
Q4 2018

Jul 13, 2023
SELL
$65.41 - $84.65 $179,354 - $232,110
-2,742 Reduced 26.52%
7,598 $538,000
Q4 2018

Mar 22, 2023
SELL
$65.41 - $84.65 $279,627 - $361,878
-4,275 Reduced 36.01%
7,598 $538,000
Q4 2018

Feb 14, 2019
SELL
$65.41 - $84.65 $279,627 - $361,878
-4,275 Reduced 36.01%
7,598 $538,000
Q3 2018

Jul 13, 2023
SELL
$85.46 - $126.37 $234,331 - $346,506
-2,742 Reduced 26.52%
7,598 $649,000
Q3 2018

Mar 22, 2023
BUY
$85.46 - $126.37 $131,010 - $193,725
1,533 Added 14.83%
11,873 $1.01 Million
Q3 2018

Nov 14, 2018
BUY
$85.46 - $126.37 $365,341 - $540,231
4,275 Added 56.26%
11,873 $1.02 Million
Q4 2017

Feb 15, 2018
BUY
$45.65 - $59.37 $346,848 - $451,093
7,598
7,598 $446,000

Others Institutions Holding ENTA

# of Institutions
108
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $109M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email